The tiny particles in the Magtrace® node marker are able to quickly pass through the lymphatic system, following the same path a spreading cancer cell would take.†

The system then guides the physician to where the liquid collects in the armpit, to see if the cancer has spread. This sentinel node biopsy procedure has helped thousands of women† avoid unnecessary and more invasive surgery.

The Magtrace® liquid has proven to be effective in numerous clinical trials involving more than 2,300+ patients across Europe and North America.†

Since those trials it has been used in over 40,000 women, in more than 350 cancer centres across more than 30 countries.† This technique allows any patient or any hospital, regardless of location, to access the highest standard in breast cancer staging.

The magnetic liquid works in as little as 20 minutes and stays in place for many days afterwards.†

This offers unrivalled flexibility on when the patient is injected, timed to coincide with a planned hospital visit or when in the operating room, under anaesthesia and pain-free.

No one wants to be injected with painful radioactive tracers and with the Magtrace® node marker nobody needs to. This safe injection eliminates radiation exposure and the need for blue dyes that may cause severe allergic reactions.†